Trials / Conditions / Metastatic Breast Adenocarcinoma
Metastatic Breast Adenocarcinoma
4 registered clinical trials studyying Metastatic Breast Adenocarcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Ca NCT05244434 | City of Hope Medical Center | N/A |
| Recruiting | A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer NCT04521764 | Mayo Clinic | Phase 1 |
| Completed | Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Canc NCT03199885 | National Cancer Institute (NCI) | Phase 3 |
| Terminated | CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer NCT02067741 | Swiss Cancer Institute | Phase 2 |